The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Phenotype associated with APP duplication in five families
Abstract
Different duplications of the APP locus have been identified in five families with autosomal dominant early onset Alzheimer's disease (ADEOAD) and Abeta-related cerebral amyloid angiopathy (CAA). This study describes the phenotype of this new entity. Clinical, neuropsychological, imagery and neuropathological data were reviewed. The phenotype was not dependent on the size of the duplication and there was no clinical feature of Down's syndrome. Dementia was observed in all cases; intracerebral haemorrhage (ICH) was reported in 6 (26%) and seizures occurred in 12 (57%) of 21 patients. Age of onset of dementia ranged from 42 to 59 years, ICH from 53 to 64 years and age at death from 46 to 75 years. The neuropathological findings in five cases demonstrated Alzheimer's disease and severe CAA lesions that were reminiscent from those reported in brains of Down's syndrome patients. A striking feature consisted in intraneuronal Abetax-40 accumulation located in the granular cell layer of the dentate gyrus and in the pyramidal cell layer of the Ammon's horn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Mendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,858
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Rovelet-Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,249
Self-citationThe 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209
Genuine memory deficits in dementia
Grober, E., & Buschke, H. (1987) · Developmental Neuropsychology · doi:10.1080/87565648709540361 · Cited by 1,047
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991
Self-citationMortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
Yang, Q., Rasmussen, S. A., & Friedman, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08092-3 · Cited by 847
Hendriks, L., van Duijn, C. M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J.-J., et al. (1992) · Nature Genetics · doi:10.1038/ng0692-218 · Cited by 734
Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706
Cardebat, D., Doyon, B., Puel, M., Goulet, P., & Joanette, Y. (1990) · PubMed · Cited by 698
Alzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 637
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 2×
“Moreover, CAA is detected in Down’s syndrome brains, even in young patients in their 30s, but tended to be more abundant in older patients (Vonsattel et al., 1991; Iwatsubo et al., 1995; Lemere et al., 1996).”
BackgroundEllis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
A Prospective Study of Alzheimer Disease in Down Syndrome
Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561
Grabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523
The changing survival profile of people with Down's syndrome: implications for genetic counselling
Glasson, E., Sullivan, S., Hussain, R., Petterson, B., Montgomery, P., & Bittles, A. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620506.x · Cited by 475
Herzig, M. C., Winkler, D. T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., Danner, S., Abramowski, D., Stürchler-Pierrat, C., Bürki, K., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1302 · Cited by 391
Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome
Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 384
Cataldo, A. M., Petanceska, S., Terio, N. B., Peterhoff, C. M., Durham, R., Mercken, M., Mehta, P. D., Buxbaum, J., Haroutunian, V., & Nixon, R. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.027 · Cited by 363
Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study
Pfeifer, L. A., White, L. R., Ross, G. W., Petrovitch, H., & Launer, L. J. (2002) · Neurology · doi:10.1212/wnl.58.11.1629 · Cited by 338
High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy
Nicoll, J. A. R., Burnett, C., Love, S., Graham, D. I., Dewar, D., Ironside, J. W., Stewart, J., & Vinters, H. V. (1997) · Annals of Neurology · doi:10.1002/ana.410410607 · Cited by 284
Intraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles
Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255
Intraneuronal Aβ-Amyloid Precedes Development of Amyloid Plaques in Down Syndrome
Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E., & Troncoso, J. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0489-iaapdo · Cited by 248
Fraser, P. E., Nguyen, J. T., Inouye, H., Surewicz, W. K., Selkoe, D. J., Podlisny, M. B., & Kirschner, D. A. (1992) · Biochemistry · doi:10.1021/bi00159a011 · Cited by 248
Cerebral amyloid angiopathy: Prospects for clinical diagnosis and treatment
Greenberg, S. M. (1998) · Neurology · doi:10.1212/wnl.51.3.690 · Cited by 243
Miravalle, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003154200 · Cited by 217
Sporadic and Familial Cerebral Amyloid Angiopathies
Revesz, T., Holton, J. L., Lashley, T., Plant, G., Rostagno, A., Ghiso, J., & Frangione, B. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00449.x · Cited by 199
The Mattis Dementia Rating Scale: Normative data from 1,001 healthy volunteers
Schmidt, R., Freidl, W., Fazekas, F., Reinhart, B., Grieshofer, P., Koch, M., Eber, B., Schumacher, M., Polmin, K., & Lechner, H. (1994) · Neurology · doi:10.1212/wnl.44.5.964 · Cited by 186
Down syndrome, Alzheimer’s disease and seizures
Menéndez, M. (2005) · Brain and Development · doi:10.1016/j.braindev.2004.07.008 · Cited by 186
(1997) · PubMed · Cited by 184
Mann, D. M. A., Pickering-Brown, S. M., Takeuchi, A., & Iwatsubo, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64688-3 · Cited by 182
Mortality and causes of death in persons with Down syndrome in California
Day, S. M., Strauss, D. J., Shavelle, R. M., & Reynolds, R. J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000319 · Cited by 176
Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice
Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., & Duyckaerts, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63405-0 · Cited by 165
Fitzpatrick, J. L., Mize, A. L., Wade, C. B., Harris, J. A., Shapiro, R. A., & Dorsa, D. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01000.x · Cited by 156
Jonghe, C. D., Zehr, C., Yager, D., Prada, C.-M., Younkin, S. G., Hendriks, L., Broeckhoven, C. V., & Eckman, C. B. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0202 · Cited by 151
Barelli, H., Lebeau, A., Vizzavona, J., Delaère, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J. D., Khorkova, O., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401708 · Cited by 144
Self-citationLife-long overexpression of S100β in Down’s syndrome: implications for Alzheimer pathogenesis
Griffin, W. S. T., Sheng, J. G., McKenzie, J. E., Royston, M. C., Gentleman, S., Brumback, R. A., Cork, L. C., Bigio, M. R. D., Roberts, G. W., & Mrak, R. E. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00074-8 · Cited by 137
Oyama, F., Cairns, N. J., Shimada, H., Oyama, R., Titani, K., & Ihara, Y. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031062.x · Cited by 132
Walsh, D. M., Hartley, D. M., Condron, M. M., Selkoe, D. J., & Teplow, D. B. (2001) · Biochemical Journal · doi:10.1042/bj3550869 · Cited by 128
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice
Seo, H., & Ole Isacson, A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.017 · Cited by 113
A novel AβPP mutation exclusively associated with cerebral amyloid angiopathy
Obici, L. P., Demarchi, A., de Rosa, G., Bellotti, V., Marciano, S., Donadei, S., Arbustini, E., Palladini, G. O., Diegoli, M., Genovese, E., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20571 · Cited by 100
Variant Alzheimer’s disease with spastic paraparesis
Verkkoniemi, A., Somer, M., Rinne, J. O., Myllykangas, L., Crook, R., Hardy, J., Viitanen, M. H., Kalimo, H., & Haltia, M. (2000) · Neurology · doi:10.1212/wnl.54.5.1103 · Cited by 96
Prevalence and Associated Features of Epilepsy in Adults with Down's Syndrome
McVicker, R. W., Shanks, O. E. P., & McClelland, R. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.528 · Cited by 90
McCarron, M. O., & Nicoll, J. A. R. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00286-9 · Cited by 88
Hereditary cerebral hemorrhage with amyloidosis‐Dutch type
Maat–Schieman, M. L. C., Roos, R. A. C., & van Duinen, S. G. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00631.x · Cited by 88
Clinical diagnosis of Down's syndrome
Jackson, J. F., North, E., & Thomas, J. G. (1976) · Clinical Genetics · doi:10.1111/j.1399-0004.1976.tb01601.x · Cited by 87
Prevalence of Epilepsy in Adults With Mental Retardation and Related Disabilities in Primary Care
McDermott, S. W., Moran, R., Platt, T., Wood, H., Isaac, T., & Dasari, S. (2004) · American Journal on Mental Retardation · Cited by 84
Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities
O’Riordan, S., McMonagle, P., Janssen, J. C., Fox, N. C., Farrell, M., Collinge, J., Rossor, M. N., & Hutchinson, M. (2002) · Neurology · doi:10.1212/wnl.59.7.1108 · Cited by 83
Nochlin, D., Bird, T. D., Nemens, E. J., Ball, M. J., & Sumi, S. M. (1998) · Annals of Neurology · doi:10.1002/ana.410430124 · Cited by 75
A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene
Rossi, G., Giaccone, G., Maletta, R., Morbin, M., Capobianco, R., Mangieri, M., Gıovagnolı, A. R., Bizzi, A., Tomaino, C., Perri, M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000137048.80666.86 · Cited by 73
van Buggenhout, G. J. C. M., Trommelen, J. C. M., Schoenmaker, A., Bal, C. D., Verbeek, J. J. M. C., Smeets, D., Ropers, H., Devriendt, K., Hamel, B. C. J., & Fryns, J. P. (1999) · American Journal of Medical Genetics · Cited by 68
Roks, G. (2000) · Brain · doi:10.1093/brain/123.10.2130 · Cited by 65
Watson, D. J., Selkoe, D. J., & Teplow, D. B. (1999) · Biochemical Journal · doi:10.1042/bj3400703 · Cited by 64
Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation
Greenberg, S. M., Shin, Y., Grabowski, T. J., Cooper, G. E., Rebeck, G. W., Iglesias, S., Chapon, F., Tournier‐Lasserve, E., & Baron, J. (2003) · Neurology · doi:10.1212/01.wnl.0000050140.10044.a8 · Cited by 62
Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation
Brooks, W. S., Kwok, J. B., Halliday, G. M., Godbolt, A. K., Rossor, M. N., Creasey, H. M., Jones, A. O., & Schofield, P. R. (2004) · Neurology · doi:10.1212/01.wnl.0000142965.10778.c7 · Cited by 44
Microbleeds in hereditary cerebral hemorrhage with amyloidosis- Dutch type
van den Boom, R., Bornebroek, M., Behloul, F., van den Berg‐Huysmans, A. A., Haan, J., & van Buchem, M. A. (2005) · Neurology · doi:10.1212/01.wnl.0000156946.44593.24 · Cited by 42
Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy
Donahue, J. E., Khurana, J. S., & Adelman, L. S. (1998) · Acta Neuropathologica · doi:10.1007/s004010050789 · Cited by 42
Natté, R., Vinters, H. V., Maat-Schieman, M. L. C., Bornebroek, M., Haan, J., Roos, R. A. C., & van Duinen, S. G. (1998) · Stroke · doi:10.1161/01.str.29.8.1588 · Cited by 41 · cited 1×
“Affected individuals suffer primarily from strokes and those who survive develop a progressive dementia (Natte et al., 1998; van den Boom et al., 2005).”
BackgroundLife expectancy of persons with chronic disabilities.
Strauss, D., & Shavelle, R. (1998) · PubMed · Cited by 38
Cerebral amyloid angiopathy in Down's syndrome.
Belza, M. G., & Urich, H. (1986) · PubMed · Cited by 37
Aoki, M., Abe, K., Oda, N., Ikeda, M., Tsuda, T., Kanai, M., Shoji, M., George‐Hyslop, P. S., & Itoyama, Y. (1997) · Neurology · doi:10.1212/wnl.48.4.1118 · Cited by 28
A Western Australian kindred with Dutch cerebral amyloid angiopathy
Panegyres, P. K., Kwok, J. B., Schofield, P. R., & Blumbergs, P. C. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.002 · Cited by 13
Cited by
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Metadata
- Authors
- Cabrejo, L., Guyant-Marechal, L., Laquerriere, A., Vercelletto, M., De La Fourniere, F., Thomas-Anterion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., Checler, F., Frebourg, T., Campion, D., & Hannequin, D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-29
- Volume
- 129
- Issue
- 11
- Pages
- 2966-2976
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1968317065
- Cited by
- 343
- References
- 71
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.